Philips incorporates Biodesix blood-based proteomic nodule risk assessment testing into Lung Cancer Orchestrator to advance early lung cancer diagnosis
June 30, 2022 09:00 ET | Royal Philips
June 30, 2022Solution adds proteomic analysis of blood-based biomarkers to Philips Lung Cancer Orchestrator to better assess the risk of lung nodule malignancy, enhancing decision-making for diagnosis...
Philips provides update on Philips Respironics’ PE-PUR sound abatement foam test and research program
June 28, 2022 01:55 ET | Royal Philips
June 28, 2022 Testing in accordance with ISO 18562 and ISO 10993 standards conducted by five certified, independent testing laboratories in the US and Europe Amsterdam, the...
Philips awarded top honor by Red Dot jury with Design Team of the Year award
June 21, 2022 04:00 ET | Royal Philips
June 21, 2022 Prestigious title awarded for the team’s multi-disciplinary and human-centered approach to designing solutions that improve people’s livesCelebratory event accompanied by presentation...
Philips_logo_logotype_emblem-700x128.png
Philips to repurchase up to 3.2 million shares to cover long-term incentive and employee stock purchase plans
June 13, 2022 10:06 ET | Royal Philips
June 13, 2022 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) today announced that it will repurchase up to 3.2 million shares to cover certain of its obligations arising from its...
Philips announces positive three-year clinical research results from its Tack Optimized Balloon Angioplasty (TOBA) II below-the-knee (BTK) clinical trial
June 13, 2022 09:00 ET | Royal Philips
June 13, 2022 For below-the-knee arterial dissection repair following balloon angioplasty, innovative medical technology shows sustained treatment effect and positive impact on quality of life for...
Philips’ Future Health Index 2022 report shows healthcare leaders are rebooting priorities as they emerge from the pandemic
June 08, 2022 10:00 ET | Royal Philips
June 8, 2022 Nearly 3,000 healthcare leaders across 15 countries reveal how they are harnessing the power of data and digital technology to address their biggest challengesImproving staff...
Philips_logo_logotype_emblem-700x128.png
Philips announces exchange ratio for 2021 dividend
June 07, 2022 05:00 ET | Royal Philips
June 7, 2022 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG; AEX: PHIA) today announced that the exchange ratio for the dividend in shares for the year 2021 has been determined. The exchange...
Willem Appelo to succeed Sophie Bechu as Philips’ Chief Operations Officer
June 07, 2022 04:00 ET | Royal Philips
June 7, 2022 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that Willem (Wim) Appelo will join Philips’ Executive Committee,...
Philips Foundation publishes its 2021 Annual Report
May 25, 2022 04:00 ET | Royal Philips
May 25, 2022 Over 17 million people in underserved communities provided with access to quality healthcare in 2021 New social impact investment vehicle established to help nurture early-stage...
Philips showcases ultra-low contrast PCI solutions at EuroPCR 2022
May 16, 2022 05:00 ET | Royal Philips
May 16, 2022 Co-registration of real-time intravascular ultrasound and/or iFR physiological assessment data onto motion-compensated angiograms aids percutaneous coronary intervention (PCI)...